The Cancer Letter

Inside information on cancer research and drug development

Guest Editorial

Cedars-Sinai Cancer’s model of care ensured patient care amid wildfires

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

Over the past five years, Cedars-Sinai Cancer has built an integrated, regional system designed to provide cancer care close to where patients live and work. This model of care, directed by an academic medical center to patients at the community level, proved to be the best possible approach to supporting patients in our 11-million-person catchment area during the worst fire disaster in California history. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Dan Theodorescu, MD, PhD
Director and PHASE ONE Foundation Distinguished Chair, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Robert A. Figlin, MD
Steven Spielberg Family Chair in Hematology Oncology, Professor of medicine and biomedical sciences, Deputy director, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Howard M. Sandler, MD
Chair, Department of Radiation Oncology, Ronald H. Bloom Family Chair in Cancer Therapeutics, Professor, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Joan August, MA
Vice president, Cedars-Sinai Cancer
Table of Contents

YOU MAY BE INTERESTED IN

Clinical Roundup

More cancers being treated with personalized therapies before surgery, National Cancer Database report shows

Breast, bladder, and pancreatic cancers are increasingly being treated with a broad range of therapies before a patient undergoes surgery, and cancer stage at diagnosis continues to be a leading factor in determining a person’s survival rate for all types of cancer, according to the first-ever annual cancer report from the National Cancer Database.
Clinical Roundup

Model created by Cedars-Sinai investigators could speed patient selection for clinical trials

A group of investigators led by Cedars-Sinai have developed and successfully tested a new artificial intelligence method to make launching cancer clinical trials easier and faster. The method uses patients’ pathology reports to automate the classification of patients by the severity of their cancers, potentially shortening the process of selecting candidates for clinical trials.
Byline
Dan Theodorescu, MD, PhD
Director and PHASE ONE Foundation Distinguished Chair, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Robert A. Figlin, MD
Steven Spielberg Family Chair in Hematology Oncology, Professor of medicine and biomedical sciences, Deputy director, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Howard M. Sandler, MD
Chair, Department of Radiation Oncology, Ronald H. Bloom Family Chair in Cancer Therapeutics, Professor, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Joan August, MA
Vice president, Cedars-Sinai Cancer
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account